chr19-48635971-C-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001352.5(DBP):c.159G>T(p.Glu53Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000565 in 1,522,296 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001352.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DBP | NM_001352.5 | c.159G>T | p.Glu53Asp | missense_variant | 2/4 | ENST00000222122.10 | NP_001343.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DBP | ENST00000222122.10 | c.159G>T | p.Glu53Asp | missense_variant | 2/4 | 1 | NM_001352.5 | ENSP00000222122.4 | ||
DBP | ENST00000601104.1 | c.159G>T | p.Glu53Asp | missense_variant | 2/3 | 1 | ENSP00000469291.1 | |||
DBP | ENST00000594723.1 | n.478G>T | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000112 AC: 14AN: 125130Hom.: 0 AF XY: 0.000158 AC XY: 11AN XY: 69496
GnomAD4 exome AF: 0.0000584 AC: 80AN: 1370102Hom.: 0 Cov.: 32 AF XY: 0.0000812 AC XY: 55AN XY: 677196
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 26, 2022 | The c.159G>T (p.E53D) alteration is located in exon 2 (coding exon 2) of the DBP gene. This alteration results from a G to T substitution at nucleotide position 159, causing the glutamic acid (E) at amino acid position 53 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at